Agency Forms Undergoing Paperwork Reduction Act Review, 73283-73285 [2021-28040]
Download as PDF
<![CDATA[
73283
Federal Register / Vol. 86, No. 245 / Monday, December 27, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent
Number of
respondents
Form name
BQASP Data Submission Form .....................
Number of
responses per
respondent
10
Average
burden per
response
(in hours)
Total burden hours
1
45/60
8
1
4
10/60
10/60
5
19
1
3
10/60
10/60
41
122
1
4
10/60
10/60
39
154
71
71
1
2
10/60
45/60
12
107
IRATB Proficiency in Arsenic Speciation (PAsS) Program
Public Health Labs .................
PAsS Enrollment Form ...................................
PAsS Data Submission Form .........................
28
28
IRATB Ensuring the Quality of Urinary Iodine Procedures (EQUIP)
Public Health Labs .................
EQUIP Enrollment Form .................................
EQUIP Data Submission Form .......................
240
240
IRATB Lead and Multielement Proficiency (LAMP) Testing Program
Public Health Labs .................
LAMP Enrollment Form ..................................
LAMP Data Submission Form ........................
226
226
NSMBB Newborn Screening and Quality Assurance Program (NSQAP)
Domestic NBS Labs ...............
International NBS Labs ..........
NBS Test Manufacturers ........
Total .................................
NSQAP Enrollment Form ...............................
NSQAP Data Submission Portal Quality Control (QC).
NSQAP Data Submission Portal Biochemical
& Molecular Proficiency Tests (PT).
NSQAP Enrollment Form ...............................
NSQAP Data Submission Portal QC ..............
NSQAP Data Submission Portal Biochemical
& Molecular PT.
NSQAP Enrollment Form ...............................
NSQAP Data Submission Portal QC ..............
NSQAP Data Submission Portal Biochemical
& Molecular PT.
71
3
45/60
160
568
568
568
1
2
3
10/60
45/60
45/60
95
129
1,278
32
32
32
1
2
3
10/60
45/60
45/60
5
48
72
.........................................................................
1,720
........................
........................
4,293
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–28033 Filed 12–23–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–1235]
khammond on DSKJM1Z7X2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Assessments
to Inform Program Refinement for HIV,
other STD, and Pregnancy Prevention
among Middle and High-School Aged
Youth’’ to the Office of Management and
Budget (OMB) for review and approval.
CDC previously published a ‘‘Proposed
Data Collection Submitted for Public
VerDate Sep<11>2014
19:11 Dec 23, 2021
Jkt 256001
Comment and Recommendations’’
notice on August 2, 2021, to obtain
comments from the public and affected
agencies. CDC received two comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
E:\FR\FM\27DEN1.SGM
27DEN1
73284
Federal Register / Vol. 86, No. 245 / Monday, December 27, 2021 / Notices
Proposed Project
Assessments to Inform Program
Refinement for HIV, other STD, and
Pregnancy Prevention among Middle
and High-School Aged Youth (OMB
Control No. 0920–1235, Exp. 05/31/
2022)—Extension—National Center for
HIV/AIDS, Viral Hepatitis, STD, TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) requests three-year
OMB approval for the extension of a
Generic Information Collection Request
(ICR) package (OMB Control No. 0920–
1235, Exp. 05/31/2022) that supports
collection of quantitative and qualitative
information from adolescents (ages 11–
19) and their parents/caregivers for the
purpose of needs assessment and
program refinement for programs and
services to prevent HIV, other sexually
transmitted diseases (STDs), and
pregnancy among middle and high
school aged adolescents.
NCHHSTP conducts behavioral and
health service assessments and research
projects as part of its response to the
domestic HIV/AIDS epidemic, STD
prevention, TB elimination and viral
hepatitis control with national, state,
and local partners. Adolescents are a
population with specific developmental,
health and social, and resource needs,
and their health risk factors and access
to health care are addressed as a
primary mission by the Division of
Adolescent and School Health (DASH).
Adolescents are also a population of
interest for several other NCHHSTP
divisions. The assessment and research
conducted by NCHHSTP is one pillar
upon which recommendations and
guidelines are revised and updated, and
these recommendations and guidelines
require a foundation of scientific
evidence.
Assessment of programmatic practices
for adolescents helps to assure effective
and evidence-based sexual risk
reduction practices and efficient use of
resources. Such assessments also help to
improve programs through better
identification of strategies relevant to
adolescents as a population, as well as
specific sub-groups of adolescents at
highest risk for HIV and other STDs so
that programs can be better tailored for
them.
The information collection requests
under this generic package are intended
to allow for data collection with two
types of respondents:
• Adolescents (11–19 years old) of
middle and high school age; and
• Parents and/or caregivers of
adolescents of middle and high school
age. For the purposes of this generic
package, parents/caregivers include the
adult primary caregiver(s) for a child’s
basic needs (e.g., food, shelter, and
safety). This includes biological parents;
other biological relatives such as
grandparents, aunts, uncles, or siblings;
and non-biological parents such as
adoptive, foster, or stepparents.
The types of information collection
activities included in this generic
package are:
(1) Quantitative data collection
through electronic, telephone, or paper
questionnaires to gather information
about programmatic and service
activities related to the prevention of
HIV and other STDs among adolescents
of middle- and high-school age.
(2) Qualitative data collection through
electronic, telephone, or paper means to
gather information about programmatic
and service activities related to the
prevention of HIV and other STDs
among adolescents of middle- and highschool age. Qualitative data collection
may involve focus groups and in-depth
interviewing through group interviews,
and cognitive interviewing.
For adolescents, data collection
instruments will include questions on
demographic characteristics;
experiences with programs and services
to reduce the risk of HIV and other STD
transmission; and knowledge, attitudes,
behaviors, and skills related to sexual
risk and protective factors on the
individual, interpersonal, and
community levels. For parents and
caregivers, data collection instruments
will include questions on demographic
characteristics as well as parents’/
caregivers’ (1) perceptions about
programs and services provided to
adolescents; (2) knowledge, attitudes,
and perceptions about their adolescents’
health risk and protective behaviors;
and (3) parenting knowledge, attitudes,
behaviors, and skills.
Any data collection request put
forward under this generic clearance
will identify the programs and/or
services to be informed or refined, and
will include a crosswalk of data
elements to the aspects of the program
the project team seeks to inform or
refine. Because this request includes a
wide range of possible data collection
instruments, specific requests will
include items of information to be
collected and copies of data collection
instruments. It is expected that all data
collection instruments will be pilot
tested, and will be culturally,
developmentally, and age appropriate
for the adolescent populations included.
Similarly, parent data collection
instruments will be pilot-tested, and the
data collection instruments will reflect
the culture, developmental stage, and
age of the parents’ adolescent children.
All data collection procedures will
receive review and approval by an
Institutional Review Board (IRB) for the
Protection of Human Subjects and
follow appropriate consent and assent
procedures as outlined in the IRB
approved protocols. These will be
described in the individual information
collection requests put forward under
this Generic package.
The table below provides the
estimated annualized response burden
for up to 15 individual data collections
per year under this generic clearance.
CDC requests approval for an estimated
57,584 annual burden hours.
Participation of respondents is
voluntary. There is no cost to
participants other than their time.
khammond on DSKJM1Z7X2PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents
Form name
Middle and High School Age Adolescents .....
Middle and High School Age Adolescents .....
Middle and High School Age Adolescents .....
Parents/caregivers of adolescents .................
Parents/caregivers of adolescents .................
Youth Questionnaire .......................................
Pre/Post youth questionnaire .........................
Youth interview/focus group guide .................
Parent/Caregiver questionnaire ......................
Parent/Caregiver interview/focus group guide
VerDate Sep<11>2014
19:11 Dec 23, 2021
Jkt 256001
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Number of
respondents
20,000
10,000
3,000
7,500
3,000
E:\FR\FM\27DEN1.SGM
27DEN1
Number of
responses per
respondent
1
2
2
2
2
Average
burden per
response
(in hours)
50/60
50/60
90/60
25/60
90/60
Federal Register / Vol. 86, No. 245 / Monday, December 27, 2021 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–28040 Filed 12–23–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2021–0001]
Final Revised Vaccine Information
Materials
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
Under the National
Childhood Vaccine Injury Act (NCVIA),
the Centers for Disease Control and
Prevention (CDC) within the
Department of Health and Human
Services (HHS) develops vaccine
information materials that all healthcare
providers are required to give to any
patient (or to the patient’s parent or
legal representative in the case where
the patient is a minor child) prior to
administration of specific vaccines. On
January 11, 2021, CDC published a
notice in the Federal Register (86 FR
1977) seeking public comments on
proposed updated vaccine information
materials for vaccines covered by the
National Vaccine Injury Compensation
Program. Following review of comments
submitted and consultation as required
under the law, CDC has finalized the
materials. By March 31, 2022, all
healthcare providers must discontinue
use of the previous editions and provide
copies of these updated vaccine
information materials prior to
immunization.
SUMMARY:
No later than March 31, 2022,
each healthcare provider who
administers a vaccine covered by the
National Vaccine Injury Compensation
Program to any child or adult in the
United States shall discontinue use of
previous editions and provide copies of
the updated vaccine information
materials referenced in this notice, in
conformance with the CDC Instructions
for Use of Vaccine Information
Statements dated October 15, 2021,
prior to administering such
vaccinations.
khammond on DSKJM1Z7X2PROD with NOTICES
DATES:
FOR FURTHER INFORMATION CONTACT:
Suzanne Johnson-DeLeon, National
Center for Immunization and
Respiratory Diseases, Centers for
VerDate Sep<11>2014
19:11 Dec 23, 2021
Jkt 256001
Disease Control and Prevention,
Mailstop: H 24–6, 1600 Clifton Road NE,
Atlanta, Georgia 30329. Telephone:
(404) 639–8817.
SUPPLEMENTARY INFORMATION: The
National Childhood Vaccine Injury Act
of 1986 (Pub. L. 99–660), as amended by
section 708 of Public Law 103–183,
added section 2126 to the Public Health
Service Act. Section 2126, codified at 42
U.S.C. 300aa–26, requires the Secretary
of Health and Human Services (the
Secretary) to develop and disseminate
vaccine information materials for
distribution by all healthcare providers
in the United States to any patient (or
to the patient’s parent or legal
representative in the case where the
patient is a minor child) receiving
vaccines covered under the National
Vaccine Injury Compensation Program.
Development and revision of the
vaccine information materials, also
known as Vaccine Information
Statements, have been delegated by the
Secretary to the Centers for Disease
Control and Prevention (CDC). Section
2126 requires the materials be
developed, or revised, after notice to the
public, with a 60-day comment period,
and in consultation with the Advisory
Commission on Childhood Vaccines,
appropriate healthcare provider and
parent organizations, and the Food and
Drug Administration. Section 2126 also
requires that the information contained
in the materials be based on available
data and information, be presented in
understandable terms, and include:
(1) A concise description of the
benefits of the vaccine;
(2) A concise description of the risks
associated with the vaccine;
(3) A statement of the availability of
the National Vaccine Injury
Compensation Program; and
(4) Such other relevant information as
may be determined by the Secretary.
The vaccines initially covered under
the National Vaccine Injury
Compensation Program were diphtheria,
tetanus, pertussis, measles, mumps,
rubella, and poliomyelitis vaccines.
Since April 15, 1992, any healthcare
provider in the United States who
intends to administer one of these
covered vaccines is required to provide
copies of the relevant vaccine
information materials prior to
administration of any of these vaccines.
Since then, the following vaccines have
been added to the National Vaccine
Injury Compensation Program, requiring
use of vaccine information materials for
them as well: hepatitis B, Haemophilus
influenzae type b (Hib), varicella
(chickenpox), pneumococcal conjugate,
rotavirus, hepatitis A, meningococcal,
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
73285
human papillomavirus (HPV), and
seasonal influenza vaccines.
Instructions for use of the vaccine
information materials are found on the
CDC website at: https://www.cdc.gov/
vaccines/hcp/vis/about/required-useinstructions.html.
Revised Vaccine Information Materials
The revised vaccine information
materials referenced in this notice were
developed in consultation with the
Advisory Commission on Childhood
Vaccines, the Food and Drug
Administration, and parent and
healthcare provider organizations.
Following consultation and review of
comments submitted, the vaccine
information materials pertaining to
vaccines covered under the National
Vaccine Injury Compensation Program
have been finalized and are available to
download from https://www.cdc.gov/
vaccines/hcp/vis/ or https://
www.regulations.gov (see Docket
Number CDC–2021–0001). The revised
Vaccine Information Statements are the
following:
‘‘DTaP (Diphtheria, Tetanus, and Pertussis)
Vaccine: What You Need to Know,’’
publication date August 6, 2021.
‘‘Hepatitis A Vaccine: What You Need to
Know,’’ publication date October 15, 2021.
‘‘Hepatitis B Vaccine: What You Need to
Know,’’ publication date October 15, 2021.
‘‘Haemophilus influenzae type b (Hib)
Vaccine: What You Need to Know,’’
publication date August 6, 2021.
‘‘HPV (Human Papillomavirus) Vaccine:
What You Need to Know,’’ publication date
August 6, 2021.
‘‘Influenza (Flu) Vaccine (Live, Intranasal):
What You Need to Know,’’ publication date
August 6, 2021.
‘‘Influenza (Flu) Vaccine (Inactivated or
Recombinant): What You Need to Know,’’
publication date August 6, 2021.
‘‘MMR Vaccine (Measles, Mumps, and
Rubella): What You Need to Know,’’
publication date August 6, 2021.
‘‘MMRV Vaccine (Measles, Mumps,
Rubella, and Varicella): What You Need to
Know,’’ publication date August 6, 2021.
‘‘Meningococcal ACWY Vaccine: What
You Need to Know,’’ publication date August
6, 2021.
‘‘Meningococcal B Vaccine: What You
Need to Know,’’ publication date August 6,
2021.
‘‘Pneumococcal Conjugate Vaccine
(PCV13): What You Need to Know,’’
publication date August 6, 2021.
‘‘Polio Vaccine: What You Need to Know,’’
publication date August 6, 2021.
‘‘Rotavirus Vaccine: What You Need to
Know,’’ publication date October 15, 2021.
‘‘Tdap (Tetanus, Diphtheria, and Pertussis)
Vaccine: What You Need to Know,’’
publication date August 6, 2021.
‘‘Td (Tetanus and Diphtheria) Vaccine:
What You Need to Know,’’ publication date
August 6, 2021.
E:\FR\FM\27DEN1.SGM
27DEN1
]]>Agencies
[Federal Register Volume 86, Number 245 (Monday, December 27, 2021)]
[Notices]
[Pages 73283-73285]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28040]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-1235]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Assessments to Inform Program Refinement
for HIV, other STD, and Pregnancy Prevention among Middle and High-
School Aged Youth'' to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
August 2, 2021, to obtain comments from the public and affected
agencies. CDC received two comments related to the previous notice.
This notice serves to allow an additional 30 days for public and
affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
[[Page 73284]]
Proposed Project
Assessments to Inform Program Refinement for HIV, other STD, and
Pregnancy Prevention among Middle and High-School Aged Youth (OMB
Control No. 0920-1235, Exp. 05/31/2022)--Extension--National Center for
HIV/AIDS, Viral Hepatitis, STD, TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) requests
three-year OMB approval for the extension of a Generic Information
Collection Request (ICR) package (OMB Control No. 0920-1235, Exp. 05/
31/2022) that supports collection of quantitative and qualitative
information from adolescents (ages 11-19) and their parents/caregivers
for the purpose of needs assessment and program refinement for programs
and services to prevent HIV, other sexually transmitted diseases
(STDs), and pregnancy among middle and high school aged adolescents.
NCHHSTP conducts behavioral and health service assessments and
research projects as part of its response to the domestic HIV/AIDS
epidemic, STD prevention, TB elimination and viral hepatitis control
with national, state, and local partners. Adolescents are a population
with specific developmental, health and social, and resource needs, and
their health risk factors and access to health care are addressed as a
primary mission by the Division of Adolescent and School Health (DASH).
Adolescents are also a population of interest for several other NCHHSTP
divisions. The assessment and research conducted by NCHHSTP is one
pillar upon which recommendations and guidelines are revised and
updated, and these recommendations and guidelines require a foundation
of scientific evidence.
Assessment of programmatic practices for adolescents helps to
assure effective and evidence-based sexual risk reduction practices and
efficient use of resources. Such assessments also help to improve
programs through better identification of strategies relevant to
adolescents as a population, as well as specific sub-groups of
adolescents at highest risk for HIV and other STDs so that programs can
be better tailored for them.
The information collection requests under this generic package are
intended to allow for data collection with two types of respondents:
Adolescents (11-19 years old) of middle and high school
age; and
Parents and/or caregivers of adolescents of middle and
high school age. For the purposes of this generic package, parents/
caregivers include the adult primary caregiver(s) for a child's basic
needs (e.g., food, shelter, and safety). This includes biological
parents; other biological relatives such as grandparents, aunts,
uncles, or siblings; and non-biological parents such as adoptive,
foster, or stepparents.
The types of information collection activities included in this
generic package are:
(1) Quantitative data collection through electronic, telephone, or
paper questionnaires to gather information about programmatic and
service activities related to the prevention of HIV and other STDs
among adolescents of middle- and high-school age.
(2) Qualitative data collection through electronic, telephone, or
paper means to gather information about programmatic and service
activities related to the prevention of HIV and other STDs among
adolescents of middle- and high-school age. Qualitative data collection
may involve focus groups and in-depth interviewing through group
interviews, and cognitive interviewing.
For adolescents, data collection instruments will include questions
on demographic characteristics; experiences with programs and services
to reduce the risk of HIV and other STD transmission; and knowledge,
attitudes, behaviors, and skills related to sexual risk and protective
factors on the individual, interpersonal, and community levels. For
parents and caregivers, data collection instruments will include
questions on demographic characteristics as well as parents'/
caregivers' (1) perceptions about programs and services provided to
adolescents; (2) knowledge, attitudes, and perceptions about their
adolescents' health risk and protective behaviors; and (3) parenting
knowledge, attitudes, behaviors, and skills.
Any data collection request put forward under this generic
clearance will identify the programs and/or services to be informed or
refined, and will include a crosswalk of data elements to the aspects
of the program the project team seeks to inform or refine. Because this
request includes a wide range of possible data collection instruments,
specific requests will include items of information to be collected and
copies of data collection instruments. It is expected that all data
collection instruments will be pilot tested, and will be culturally,
developmentally, and age appropriate for the adolescent populations
included.
Similarly, parent data collection instruments will be pilot-tested,
and the data collection instruments will reflect the culture,
developmental stage, and age of the parents' adolescent children. All
data collection procedures will receive review and approval by an
Institutional Review Board (IRB) for the Protection of Human Subjects
and follow appropriate consent and assent procedures as outlined in the
IRB approved protocols. These will be described in the individual
information collection requests put forward under this Generic package.
The table below provides the estimated annualized response burden
for up to 15 individual data collections per year under this generic
clearance. CDC requests approval for an estimated 57,584 annual burden
hours. Participation of respondents is voluntary. There is no cost to
participants other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Middle and High School Age Adolescents Youth Questionnaire..... 20,000 1 50/60
Middle and High School Age Adolescents Pre/Post youth 10,000 2 50/60
questionnaire.
Middle and High School Age Adolescents Youth interview/focus 3,000 2 90/60
group guide.
Parents/caregivers of adolescents..... Parent/Caregiver 7,500 2 25/60
questionnaire.
Parents/caregivers of adolescents..... Parent/Caregiver 3,000 2 90/60
interview/focus group
guide.
----------------------------------------------------------------------------------------------------------------
[[Page 73285]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-28040 Filed 12-23-21; 8:45 am]
BILLING CODE 4163-18-P
